By Dr Alexander Radbruch
The significance of the finding of gadolinium depositions in the brain following serial injections of gadolinium based contrast agents (GBCAs) is the subject of on-going active scientific research and debate, which are being carried out against the background of different regulatory actions being adopted in the United States and in Europe.